Mammalian target of rapamycin inhibitors for the treatment of astrocytic hamartoma in tuberous sclerosis complex (TSC)

被引：0
|
作者：
Ofri Vorobichik Berar
Michal Tzadok
Ofira Zloto
Iris Moroz
Idan Hecht
Anne Ampaire Musika
Omer Shlomovitz
Ido-Didi Fabian
Vicktoria Vishnevskia Dai
机构：
[1] Sheba Medical Center,Goldschleger Eye Institute
[2] Safra Children’s Hospital,Pediatric Neurology Unit
[3] Sheba Medical Center,Sackler Faculty of Medicine
[4] Tel Aviv University,Department of Ophthalmology
[5] Shamir Medical Center,Department of Ophthalmology
[6] College of Health Science,undefined
[7] Makerere University,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2022年 / 260卷
关键词：
Tuberous sclerosis complex; Retinal astrocytic hamartoma; mTOR inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3061 / 3068
页数：7
相关论文
共 50 条
  • [1] Mammalian target of rapamycin inhibitors for the treatment of astrocytic hamartoma in tuberous sclerosis complex (TSC)
    Berar, Ofri Vorobichik
    Tzadok, Michal
    Zloto, Ofira
    Moroz, Iris
    Hecht, Idan
    Musika, Anne Ampaire
    Shlomovitz, Omer
    Fabian, Ido-Didi
    Dai, Vicktoria Vishnevskia
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (09) : 3061 - 3068
  • [2] Mammalian target of rapamycin and tuberous sclerosis complex
    Wataya-Kaneda, Mari
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2015, 79 (02) : 93 - 100
  • [3] Regressed Retinal Astrocytic Hamartomas in Tuberous Sclerosis by Mammalian Target of Rapamycin Inhibitor (Everolimus) Treatment
    Kim, Hyuna
    Park, Song-hee
    [J]. JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2021, 62 (06): : 862 - 866
  • [4] Safety Considerations of Mammalian Target of Rapamycin Inhibitors in Tuberous Sclerosis Complex and Renal Transplantation
    Somers, Michael J. G.
    Paul, Elahna
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (04): : 368 - 376
  • [5] Mammalian Target of Rapamycin Inhibitors and Life-Threatening Conditions in Tuberous Sclerosis Complex
    Moavero, Romina
    Romagnoli, Gloria
    Graziola, Federica
    Curatolo, Paolo
    [J]. SEMINARS IN PEDIATRIC NEUROLOGY, 2015, 22 (04) : 282 - 294
  • [6] Renal cell carcinoma associated with tuberous sclerosis complex (TSC)/mammalian target of rapamycin (MTOR) genetic alterations
    Argani, Pedram
    Mehra, Rohit
    [J]. MODERN PATHOLOGY, 2022, 35 (03) : 296 - 297
  • [7] Retinal astrocytic hamartoma in a patient with tuberous sclerosis complex
    Yamamoto, D.
    Makino, S.
    Tampo, H.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2023, 116 (11) : 933 - 935
  • [8] Mammalian Target of Rapamycin Inhibitors for Intractable Epilepsy and Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex
    Cardamone, Michael
    Flanagan, Danny
    Mowat, David
    Kennedy, Sean E.
    Chopra, Maya
    Lawson, John A.
    [J]. JOURNAL OF PEDIATRICS, 2014, 164 (05): : 1195 - 1200
  • [9] Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis
    Sheth, Rahul A.
    Feldman, Adam S.
    Paul, Elahna
    Thiele, Elizabeth A.
    Walker, T. Gregory
    [J]. WORLD JOURNAL OF RADIOLOGY, 2016, 8 (03): : 308 - 315
  • [10] Sirolimus for Retinal Astrocytic Hamartoma Associated with Tuberous Sclerosis Complex
    Zhang, Zhi-Qiao
    Shen, Cheng
    Long, Qin
    Yang, Zhi-Kun
    Dai, Rong-Ping
    Wang, Jun
    Zhang, Weihong
    Pan, Qingqing
    Zhu, Zhaohui
    Xu, Kai-Feng
    [J]. OPHTHALMOLOGY, 2015, 122 (09) : 1947 - 1949
12345